USPTO serial 86580747
FHT
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BENMAMAN, ALICE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Francisco, CA
San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle L. Mehok
MICHELLE L. MEHOK Pillsbury Winthrop Shaw Pittman Llp12255 El Camino Real Ste 300San Diego, CA 92130-4088UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Genomic and bioinformatics testing, namely, genetic testing for medical research and scientific research purposes; genetic mapping for scientific purposes; scientific and technology services in the nature of scientific research and development in the field of bioinformatics, genes, genomics, and gene expression; genomic sequencing services for medical research and scientific research purposes; DNA testing and screening for scientific research purposes; DNA analysis and screening for scientific research purposes; DNA analysis services for scientific research purposes; scientific research in the field of genetics, namely, gene screening, gene identification, gene isolation and gene expression measurement services; providing an online database in the field of bioinformatics scientific research and medical discovery research; providing online non-downloadable software applications for providing clinical decision support, as well as providing an online database featuring medical and scientific research information in the field of genetics based on results of genotyping, medical records, and genomic sequencing all in the fields of genetics, genomics, genotyping, phenotyping, ancestry; pharmacogenetic testing and bioinformatics analysis for scientific research purposes | ACTIVE | — |
| 044 | Medical services; genetic testing for medical purposes; medical testing for diagnosis of diseases for use in connection with diagnostic testing; genomic and bioinformatics testing, namely, genetic testing for medical diagnostic and treatment purposes; DNA screening for medical diagnostic and treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; DNA screening for medical purposes; pharmacogenetic testing and bioinformatics analysis for medical purposes; medical testing services for diagnostic and treatment purposes, namely, providing medical tests that measure, analyze and interpret genes of patients, environmental, and other factors to predict which drugs or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment options and choices for patients, identify potentially harmful drug interactions and calculate drug dosage adjustments for patients; testing services, namely, genetic sequencing for medical, diagnostic and treatment purposes; genetic diagnostic testing services; providing an online database featuring medical information concerning genetic testing and bioinformatics analysis for the purpose of diagnosing family inherited diseases; DNA analysis for medical purposes; providing an online database in the field of bioinformatics for medical diagnostic or treatment purposes; providing an online database featuring medical information in the field of genetics based on results of genotyping, medical records, and genomic sequencing all in the fields of genetics, genomics, genotyping, phenotyping, ancestry | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 23, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 20, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 18, 2017 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 18, 2017 | EXT4 | SOU EXTENSION 4 FILED | — |
| Dec 18, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 23, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 21, 2017 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 21, 2017 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 21, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 27, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 27, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 16, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 14, 2016 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 14, 2016 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 14, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 19, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 20, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 20, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 20, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 22, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 27, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 27, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 7, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 24, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 17, 2015 | ALIE | ASSIGNED TO LIE | — |
| Aug 24, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 24, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2015 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 13, 2015 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 13, 2015 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 6, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2015 | NWAP | NEW APPLICATION ENTERED | — |